Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Myelodysplastic Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT00843882
What this trial is testing

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Who this might be right for
AnemiaChronic Myelomonocytic LeukemiaDe Novo Myelodysplastic Syndrome+1 more
National Cancer Institute (NCI) 247
Testing effectiveness (Phase 2)Ended earlyNCT01795924
What this trial is testing

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Biosuccess Biotech Co., Ltd. 13
Testing effectiveness (Phase 2)Study completedNCT00744536
What this trial is testing

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicAngiogenesis
Sunnybrook Health Sciences Centre 20
Testing effectiveness (Phase 2)Study completedNCT01081431
What this trial is testing

Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q

Who this might be right for
Myelodysplastic Syndromes
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 91
Testing effectiveness (Phase 2)Ended earlyNCT01191749
What this trial is testing

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)UnknownNCT04997811
What this trial is testing

Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes (MDS)
Prof. Janet Dunn 120
Not applicableStudy completedNCT04036448
What this trial is testing

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

Who this might be right for
Myelodysplastic SyndromesLymphoma, Mantle-CellLymphoma, Follicular
Celgene 28
Not applicableUnknownNCT01331603
What this trial is testing

Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis

Who this might be right for
Myelodysplastic SyndromePrimary Myelofibrosis
Wolfson Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT02428686
What this trial is testing

Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 50
Not applicableStudy completedNCT01855698
What this trial is testing

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Who this might be right for
Hematologic NeoplasmAcute LeukemiaMyelodysplastic Syndrome+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 99
Testing effectiveness (Phase 2)Ended earlyNCT00379912
What this trial is testing

Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Larry Cripe, MD 15
Early research (Phase 1)WithdrawnNCT02075034
What this trial is testing

Three Dosing Schedules of Oral Rigosertib in MDS Patients

Who this might be right for
Myelodysplastic Syndrome
Traws Pharma, Inc.
Testing effectiveness (Phase 2)Study completedNCT00008151
What this trial is testing

Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT04324060
What this trial is testing

Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia

Who this might be right for
Low/Intermediate Risk-1 MDS
Peking Union Medical College Hospital 75
Not applicableApproved For MarketingNCT05937568
What this trial is testing

Expanded Access for Treatment With Imetelstat

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation
Not applicableLooking for participantsNCT02958462
What this trial is testing

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Who this might be right for
Myeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more
Mayo Clinic 2,000
Large-scale testing (Phase 3)Ended earlyNCT01366612
What this trial is testing

Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

Who this might be right for
Myeloid MalignanciesAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
Hackensack Meridian Health 53
Testing effectiveness (Phase 2)Study completedNCT00897130
What this trial is testing

5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)

Who this might be right for
Myelodysplastic Syndrome
Università degli Studi di Brescia 28
Testing effectiveness (Phase 2)Study completedNCT00001637
What this trial is testing

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 28
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Next Page